Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study
1 Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Institute of Molecular Oncology and Functional Genomics, School of Medicine, TU München, Munich, Germany. Electronic address: [email protected].
2 Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany.
3 InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
4 Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
5 Department of Medicine II, Division of Hepatology, Division of Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-Württemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
6 Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
7 Institute of Molecular Oncology and Functional Genomics, School of Medicine, TU München, Munich, Germany.
8 Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
9 Department of Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, Metabolic Disorders, Oncology, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
10 German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Internal Medicine II, Klinikum rechts der Isar, TU München, Munich, Germany.
11 Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
12 Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; Department of Pharmaceutical Biology, LMU Munich, Munich, Germany.